The National Institutes of Health has awarded Lucigen $750,000 to be used over two years to develop enzymes and methods for nucleic acid sequencing. This work may lead to faster and less expensive methods of sequencing DNA, which is important in the emerging field of...
Four advanced pieces of scientific laboratory equipment worth approximately $1 million was donated by the private WiCell Research Institute. WiCell made the gifts as part of its ongoing efforts to support stem cell research on campus and the work of the university's Stem Cell...
Even the best seeds can take a while to germinate. A case in point is the proposal to open seven “emerging technology centers” on University of Wisconsin System campuses to better serve industry while engaging faculty and student research talent. The UW Board of Regents...
Cellular Dynamics and Sittingbourne, England-based VivoMedica have launched a consortium to validate a human cell model and analysis system, based on the firms' technologies, for preclinical cardiotoxicity testing of drug candidates. The consortium will be formally launched at the Safety Pharmacology Society 9th Annual...
Wisconsin economic development gurus love to tout Madison as one of the world's rising biotech "hot spots." But Madison's biotechnology scene gets an unflattering mention in a new report detailed in the Scientist magazine - for having some of the lowest life sciences salaries in the...
In recent years, the top tier Japanese pharma companies, in order to compete against international incursion in its own $78.6 billion home market (or about 10% of the global pharma market), has been forced to globalize. Add to this that the Japanese market growth has...
Stratatech Corp. will launch the full-thickness human skin product, called StrataTest, in Dresden, Germany, at Eurotox 2009, the annual meeting of European toxicologists. The company says it expects its research-only product to be a compelling alternative for makers of everything from shampoo to mascara to...
Scarab Genomics, a leader in E coli technology, has entered into a license agreement with NeoClone to market and distribute their proprietary antibodies against Shiga toxin. According to Frederick R. Blattner, PhD, founder and President of Scarab Genomics, the research and diagnostic markets will...
The University of Wisconsin, Madison, is one of the country's leading centers of public biopharmaceutical research, and the campus has spawned dozens of spinout companies based on University research. Given the right conditions that growth could, over the next five years, support the emergence...
Last week the New York Times reported that the FDA put a clinical hold on Geron's pioneering human embryonic stem cell (ESC) trial—before the first patient could be enrolled. In what was to be the world's first clinical test of ESCs, Geron planned to differentiate...